News

From Approval to Treatment, the History of Ipilimumab


 

In conjunction with the Food and Drug Administration's impending approval of another drug for melanoma treatment, vemurafenib, we present this look on the late-stage melanoma drug ipilimumab, how it was approved and the response that followed.

<a href="http://storify.com/ciminosteve/ipilimumab" target="_blank">View "Melanoma Treatment With Ipilimumab (Yervoy)" on Storify</a>

Recommended Reading

FDA Okay Expected Soon for Melanoma Drug Ipilimumab
MDedge Internal Medicine
FDA: Ipilimumab Approved for Metastatic Melanoma
MDedge Internal Medicine
Once Again, Results Mixed for SN Biopsy in Melanoma
MDedge Internal Medicine
FDA Approves Peginterferon Alfa-2b for Melanoma
MDedge Internal Medicine
Thin vs. Thick Melanomas: Both Carry Same SLN Involvement Risk
MDedge Internal Medicine
Lymphatic Invasion Predicts Recurrence in Merkel Cell Cancer
MDedge Internal Medicine
Ipilimumab and Beyond: New Therapies Imminent in Melanoma
MDedge Internal Medicine
BRAF Inhibitor Cuts Death Risk in Advanced Melanoma
MDedge Internal Medicine
Ipilimumab Added to Dacarbazine Prolongs Survival for Metastatic Melanoma
MDedge Internal Medicine
Video of the Week: More Melanoma Treatments on the Way?
MDedge Internal Medicine